Reducing the side effects of radiotherapy for prostate cancer patients

SpaceOar Hydrogel is available as part of the standard treatment plan for prostate cancer at GenesisCare.

In an article, published in the Guardian in 2018, Dr Philip Camilleri, Consultant Clinical Oncologist, and Mr Simon Brewer, Consultant Urology Surgeon, discuss how the harmless gel works to reduce the side-effects of radiotherapy that may otherwise include bowel toxicity and erectile dysfunction.

Placed in position under anaesthetic in around 20 minutes, they explain the day-case procedure to insert the gel has few reported side-effects and gives oncologists the option of using more powerful stereotactic radiotherapy. This technology dramatically reduces the number of radiotherapy sessions patients need to attend.

Related articles

Honouring Clinical Excellence & Leadership: GenesisCare Launches Inaugural Global Physician Recognition Program

GenesisCare Appoints Seven Leading Oncologists to Chair its Global Research Committees

SABR Consortium Annual Professional Conference 2021

Annual research report 2020